Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Dignass

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
Plos One|July 10, 2008
Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycleDaniela Paclik, Silvio Danese, Uta Berndt, et al.
European Journal of Nutrition|November 11, 2008
Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitroClaudia Guzy, Anja Schirbel, Daniela Paclik, et al.
Expert Opinion on Emerging Drugs|June 20, 2026
Obefazimod (ABX464) for Moderate-to-Severe Crohn's disease: clinical development of a novel oral therapeutic approachSailish Honap, Axel Dignass, Vipul Jairath, et al.
Expert Review of Gastroenterology & Hepatology|June 27, 2026
Anti-fibrotic therapy in Crohn's disease: hype or reality-can intestinal fibrosis Be targeted effectively?Sailish Honap, Axel Dignass, Vipul Jairath, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 15, 2020
[A surgically relevant summary of the addendum to the S3 guidelines of the DGVS on Crohn's disease and ulcerative colitis : Treatment of chronic inflammatory bowel diseases in the COVID-19 pandemic]Philip C Grunert, Axel Dignass, Torsten Kucharzik, et al.
Journal of Crohn'S & Colitis|June 30, 2018
Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily PracticeJürgen Stein, Aysegül Aksan, Wolfgang Klemm, et al.
Zeitschrift Fur Gastroenterologie|March 16, 2019
Perianal fistulas in adult patients with Crohn's disease in Germany - a retrospective cross-sectional analysis of claims data from German sickness fundsElena Georgiadou, Lena Fanter, Alina Brandes, et al.
Clinical Laboratory|March 15, 2019
Serum Hepcidin Levels Predict Intestinal Iron Absorption in Patients with Inflammatory Bowel DiseaseAyşegül Aksan, Miriam Wohlrath, Tariq H Iqbal, et al.
Journal of Crohn'S & Colitis|April 12, 2014
Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD StudyIrina Blumenstein, Axel Dignass, Stephan Vollmer, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresisLena Oxelmark, Pernilla Hillerås, Axel Dignass, et al.
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Plos One|July 10, 2008
Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycleDaniela Paclik, Silvio Danese, Uta Berndt, et al.
European Journal of Nutrition|November 11, 2008
Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitroClaudia Guzy, Anja Schirbel, Daniela Paclik, et al.
Expert Opinion on Emerging Drugs|June 20, 2026
Obefazimod (ABX464) for Moderate-to-Severe Crohn's disease: clinical development of a novel oral therapeutic approachSailish Honap, Axel Dignass, Vipul Jairath, et al.
Expert Review of Gastroenterology & Hepatology|June 27, 2026
Anti-fibrotic therapy in Crohn's disease: hype or reality-can intestinal fibrosis Be targeted effectively?Sailish Honap, Axel Dignass, Vipul Jairath, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 15, 2020
[A surgically relevant summary of the addendum to the S3 guidelines of the DGVS on Crohn's disease and ulcerative colitis : Treatment of chronic inflammatory bowel diseases in the COVID-19 pandemic]Philip C Grunert, Axel Dignass, Torsten Kucharzik, et al.
Journal of Crohn'S & Colitis|June 30, 2018
Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily PracticeJürgen Stein, Aysegül Aksan, Wolfgang Klemm, et al.
Zeitschrift Fur Gastroenterologie|March 16, 2019
Perianal fistulas in adult patients with Crohn's disease in Germany - a retrospective cross-sectional analysis of claims data from German sickness fundsElena Georgiadou, Lena Fanter, Alina Brandes, et al.
Clinical Laboratory|March 15, 2019
Serum Hepcidin Levels Predict Intestinal Iron Absorption in Patients with Inflammatory Bowel DiseaseAyşegül Aksan, Miriam Wohlrath, Tariq H Iqbal, et al.
Journal of Crohn'S & Colitis|April 12, 2014
Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD StudyIrina Blumenstein, Axel Dignass, Stephan Vollmer, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresisLena Oxelmark, Pernilla Hillerås, Axel Dignass, et al.
Pageof 18